Is the Options Market Predicting a Spike in HCA Healthcare Stock?
Investors need to pay close attention to HCA stock based on the movements in the options market lately.
Zacks Investment Research7/8/2026Neutral
HCA
HCA Healthcare, Inc.NYSEHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$91.09B
P/E Ratio
14.58
EPS
$28.17
Beta
1.13
52W High
$554.58
52W Low
$327.78
50-Day MA
$401.10
200-Day MA
$460.02
Dividend Yield
0.69%
Profit Margin
8.89%
Forward P/E
13.95
PEG Ratio
1.28
About HCA Healthcare, Inc.
HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.
Fundamentals
| Revenue (TTM) | $76.39B |
| Gross Profit (TTM) | $31.79B |
| EBITDA | $15.57B |
| Operating Margin | 15.00% |
| Return on Equity | 136.30% |
| Return on Assets | 12.30% |
| Revenue/Share (TTM) | $331.29 |
| Book Value | $-28.32 |
| Price-to-Book | 291.34 |
| Price-to-Sales (TTM) | 1.19 |
| EV/Revenue | 1.869 |
| EV/EBITDA | 9.11 |
| Quarterly Earnings Growth (YoY) | 10.90% |
| Quarterly Revenue Growth (YoY) | 4.30% |
| Shares Outstanding | $221.84M |
| Float | $149.49M |
| % Insiders | 16.21% |
| % Institutions | 78.37% |
Historical Volatility
HV 10-Day
29.57%
HV 20-Day
31.56%
HV 30-Day
31.26%
HV 60-Day
33.63%
HV Rank
79.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($497.29 target)
2
Strong Buy13
Buy9
Hold1
SellLatest News
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Benzinga7/8/2026Negative
HCA Healthcare's Fall Shouldn't Be Construed As Failing Health
HCA Healthcare remains a soft 'buy' despite recent underperformance, with fundamentals improving and shares attractively priced on an absolute basis. HCA's revenue and profitability continue to grow, driven by Medicare/Medicaid, increased equivalent admissions, and higher revenue per admission, even as the physical footprint shrinks. Management sustains shareholder returns through dividends and aggressive buybacks, with a 6.9% reduction in share count and $9.18 billion in remaining buyback capacity.
Seeking Alpha7/8/2026Neutral
Can HCA's Capacity Expansion Strategy Fuel Its Long-Term Growth?
HCA is expanding hospitals, ERs and outpatient sites while investing billions in new capacity to support future healthcare demand and long-term growth.
Zacks Investment Research7/7/2026Positive
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Zacks Investment Research7/6/2026Positive
Can HCA's Gene Therapy Milestone Drive Long-Term Growth?
HCA Healthcare highlights promising pediatric CRISPR gene therapy results as expanding specialty care and research investments support its long-term growth strategy.
Zacks Investment Research7/1/2026Positive
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced new research published in The New England Journal of Medicine (NEJM) demonstrating promising results from a gene-editing therapy being investigated in children ages 5-11 with severe sickle cell disease and transfusion-dependent beta thalassemia. Sickle cell disease and beta thalassemia are inherited blood disorders that can cause serious, lifelong complications b.
Business Wire6/29/2026Neutral
HCA Healthcare (HCA) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research6/26/2026Positive
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Zacks Investment Research6/25/2026Positive
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research6/24/2026Positive
More HEALTHCARE Stocks
Data last updated: 7/9/2026